|
|
Article: Treatment options for the management of perennial allergic rhinitis, with a focus on intranasal corticosteroids.(Review Article)(Disease/Disorder overview)
- Article from:
- Southern Medical Journal
- Article date:
- July 1, 2007
- Author:
CopyrightCOPYRIGHT 2007 Southern Medical Association. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Abstract: Perennial allergic rhinitis (PAR) can have a significant impact on a patient's quality of life. While allergen avoidance is the first line of management for PAR, complete avoidance is difficult. Therapeutic options available for PAR include intranasal corticosteroids (INS), [H.sub.1]-antihistamines, decongestants and local chromones, as well as immunotherapy. For mild symptoms, INS and antihistamines are the standard of care, whereas for moderate-to-severe PAR, INS are the preferred therapy due to their proven efficacy. Patient quality of life and therapy preference play a role in maintaining adherence to treatment.
Key Words: perennial allergic ...